New Menendez Campaign Ad Slams Hugin for Putting Profits above Patients

Hugin, Celgene Pay $280M to settle lawsuit alleging they put ‘patients at risk’ to ‘boost sales’

New Brunswick, NJ – The Menendez for Senate Campaign today released a new television ad entitled “Side Effects” highlighting how greedy CEO Bob Hugin’s drug company paid $280 million to settle federal whistleblower fraud charges that it lied to doctors and patients about their drug’s potentially fatal side effects, putting “patients at risk” to “boost sales.”

“Bob Hugin and Celgene were accused of putting cancer patients at risk of further physical harm just to boost sales and pad their own pockets.  Bob Hugin didn’t take a stand and defend himself and his company against charges they broke federal law.  Instead, he paid $280 million to avoid trial and make his problems go away,” said Menendez for Senate Communications Director Steve Sandberg.  “It’s time greedy CEO Bob Hugin come clean about how he made his fortune putting profits above patients.  He personally made $100 million allegedly putting lives at risk.  New Jersey voters have a right to know how many cancer patients suffered at the hands of Bob Hugin’s corrupt and craven practices as the head of pharma giant Celgene.”